EGR1 and uveal melanoma: Considering the roles of EGR1 as an indicator of the MAPK cascade activity, a determinant of MEKi efficacy, and a correlate of clinical outcomes in uveal melanoma, we explored whether the addition of IMPDHi to a MEKi enhances the suppression of EGR1 expression.